Synthesis and Biological Evaluation of Novel Thiazolyl-Coumarin Derivatives as Potent Histone Deacetylase Inhibitors with Antifibrotic Activity
Open Access
Abstract
New histone deacetylases (HDAC) inhibitors with low toxicity to non-cancerous cells, are a prevalent issue at present because these enzymes are actively involved in fibrotic diseases. We designed and synthesized a novel series of thiazolyl-coumarins, substituted at position 6 (R = H, Br, OCH3), linked to classic zinc binding groups, such as hydroxamic and carboxylic acid moieties and alternative zinc binding groups such as disulfide and catechol. Their in vitro inhibitory activities against HDACs were evaluated. Disulfide and hydroxamic acid derivatives were the most potent ones. Assays with neonatal rat cardiac fibroblasts demonstrated low cytotoxic effects for all compounds. Regarding the parameters associated to cardiac fibrosis development, the compounds showed antiproliferative effects, and triggered a strong decrease on the expression levels of both α-SMA and procollagen I. In conclusion, the new thiazolyl-coumarin derivatives inhibit HDAC activity and decrease profibrotic effects on cardiac fibroblasts.Keywords
Funding Information
- Comisión Nacional de Investigación Científica y Tecnológica (21140371 to Viviana Pardo Jiménez, FONDECYT Grant N° 1130300 and N° 1170425)
This publication has 54 references indexed in Scilit:
- Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR SignalingPLOS ONE, 2013
- Histone Deacetylase: A Potential Therapeutic Target for Fibrotic DisordersThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potentialBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studiesBioorganic & Medicinal Chemistry, 2009
- FibrosisJACC, 2008
- Synthesis of novel triheterocyclic thiazoles as anti-inflammatory and analgesic agentsEuropean Journal of Medicinal Chemistry, 2007
- A Metabolic Screening Study of Trichostatin A (TSA) and TSA-Like Histone Deacetylase Inhibitors in Rat and Human Primary Hepatocyte CulturesThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Solution-phase Synthesis of a Combinatorial Library of 3-[4-(Coumarin-3-yl)-1,3-thiazol-2-ylcarbamoyl]propanoic acid AmidesMolecules, 2005
- Antioxidant activities of dithiol alpha-lipoic acidBangladesh Journal of Medical Science, 1970